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Summary
 
Efficient loading of major histocompatibility complex class II molecules with peptides requires
the invariant chain (Ii) and the class II–like molecule H-2M. Recent in vitro biochemical stud-
ies suggest that H2-M may function as a chaperone to rescue empty class II dimers. To test this
hypothesis in vivo, we generated mice lacking both Ii and H-2M (Ii
 
2/2
 
M
 
2/2
 
). Antigen pre-
senting cells (APCs) from Ii
 
2/2
 
M
 
2/2
 
 mice, as compared with APCs from Ii
 
2/2
 
 mice, exhibit a
significant reduction in their ability to present self-peptides to a panel of class II I-A
 
b
 
–restricted
T cells. As a consequence of this defect in the loading of self peptides, CD4
 
1
 
 thymocyte devel-
opment is profoundly impaired in Ii
 
2/2
 
M
 
2/2
 
 mice, resulting in a peripheral CD4
 
1
 
 T cell pop-
ulation with low levels of T cell receptor expression. These findings are consistent with the
idea that H-2M functions as a chaperone in the peptide loading of class II molecules in vivo.
 
N
 
ewly synthesized MHC class II 
 
a
 
/
 
b
 
 dimers are as-
sembled in the endoplasmic reticulum by association
with invariant chain (Ii)
 
1
 
 and then transported into endocytic
vesicles (MHC class II peptide–loading compartment MIIC
or CIIV) with lysosomal and endosomal characteristics,
where Ii is proteolytically degraded (for review see refer-
ence 1). The final products of Ii processing are short frag-
ments originating from the 81–104 region of Ii, termed
CLIP (class II–associated invariant chain peptide), which
remain bound to the groove of class II molecules until they
are exchanged for self or foreign peptides (2). Mice lacking
Ii (Ii
 
2/2
 
) have significantly reduced expression of cell sur-
face class II molecules, and have only small numbers of
CD4
 
1
 
 T cells in the thymus and periphery (3, 4). Ii
 
2/2
 
splenocytes are severely deficient in presentation of the ma-
jority of exogenous protein antigens yet are more amenable
to loading of cell surface class II molecules with exoge-
nously supplied peptides. Biochemical experiments have
shown that in Ii
 
2/2
 
 cells, class II molecules are associated
with 20–50-kD polypeptides (5). However, endogenous
peptide–class II complexes, discernible by T cells, have been
detected in Ii-negative fibroblasts (6) or in Ii
 
2/2
 
 mice carry-
ing a known epitope encoded by a transgene (7).
The class II–like molecule, H-2M (or HLA-DM in hu-
mans) uniquely resides in MIIC or CIIV vesicles (8), and
binds to class II molecules at the low pH of these acidic or-
ganelles (9, 10). Experiments with purified class II and
HLA-DM molecules have provided clues to potential func-
tions of HLA-DM in vivo (for review see reference 11). In
these experiments, HLA-DM was shown to catalyze anti-
genic peptide loading by accelerating the dissociation of
CLIP, to act as a peptide editor by removing those peptides
with high dissociation rates, and to prevent isolated empty
class II 
 
a
 
/
 
b
 
 dimers from unfolding or aggregating at low
pH (10–15). The consequences of H-2M or HLA-DM de-
ficiency include the predominant expression of CLIP–class
II complexes and profound defects in presentation of exog-
enous antigens (16–19). However, this defect is not abso-
lute in that some peptides derived from endogenous or ex-
ogenous antigens have been shown to be displayed by class
II molecules in the absence of HLA-DM or H-2M (20–
22). Although the abundance of CLIP–class II complexes
does not alter the level of surface class II expression, mice
lacking H-2M (M
 
2/2
 
) do have moderately reduced num-
bers of CD4
 
1
 
 T cells in the thymus and periphery, reflect-
ing the altered peptide repertoire displayed by class II mol-
ecules.
To investigate the in vivo functions of H-2M other than
facilitating the removal of CLIP, we analyzed mutant mice
lacking both Ii and H-2M (Ii
 
2/2
 
M
 
2/2
 
). A recent publica-
 
1
 
Abbreviations used in this paper:
 
 AAT, aspartate aminotransferase; CLIP,
Class II associated invariant chain peptide; Ii, invariant chain; LDLr, LDL
receptor; M, H-2M.
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tion also describing these mice reported that maturation,
transport, and surface expression of class II molecules was
comparable in Ii
 
2/2
 
 and Ii
 
2/2
 
M
 
2/2
 
 splenocytes (23). Sur-
prisingly enough in view of these data, CD4
 
1
 
 T cell devel-
opment in Ii
 
2/2
 
M
 
2/2
 
 mice was impaired profoundly com-
pared to mice lacking either Ii or H-2M alone, a finding
not explained by the published analyses of the mice (23).
We hypothesized that the limited repertoire of class II–
bound self peptides displayed by Ii
 
2/2
 
 cells, accounting for
CD4
 
1
 
 T cell development in Ii
 
2/2
 
 mice, is dramatically re-
duced in Ii
 
2/2
 
M
 
2/2
 
 mice because an Ii-independent H-2M
function is required for the presentation of the majority of
endogenous peptides. To assess the effect of H-2M on the
loading of high-affinity endogenous self peptides, we gen-
erated a novel panel of T cells specific for self peptide–I-A
 
b
 
complexes. We found that the presentation of the majority
of these self epitopes was significantly reduced in the dou-
bly mutant Ii
 
2/2
 
M
 
2/2
 
 APCs, relative to Ii
 
2/2
 
 APCs. These
studies demonstrate that even in the absence of Ii, H-2M
can greatly enhance self peptide–class II complex forma-
tion, suggesting that it functions as a general chaperone in
the peptide loading process. In addition, our data suggest
that in the absence of Ii, surface class II molecules that inter-
nalize into or traffic through the endocytic pathway have
access to the variety of antigenic peptides that are present in
H-2M–containing early and late endocytic compartments.
 
Materials and Methods
 
Animals.
 
Each of the mutant mice used in this study are of a
mixed B6x129 (H-2
 
b
 
) background, which expresses the MHC
class II molecule I-A
 
b
 
. Thus, the phenotypes of Ii
 
2
 
/
 
2
 
 (4), M
 
2
 
/
 
2
 
(19), or Ii
 
2
 
/
 
2
 
M
 
2
 
/
 
2
 
 mice were compared to that of wild-type
B6x129 mice. Ii
 
2
 
/
 
2
 
 and M
 
2
 
/
 
2
 
 mice were bred to yield mice
lacking both Ii and H-2M. All wild-type and mutant mouse
strains were maintained under specific pathogen-free conditions
at Vanderbilt University or University of Washington. Ii
 
2
 
/
 
2
 
 mice
were provided by Dr. Elizabeth Bikoff (Harvard University, Cam-
bridge, MA). MHC-II
 
2
 
/
 
2
 
 mice were purchased from Taconic
Farms Inc. (Germantown, NY). Mice were used at 6–8 wk of age.
 
FACS
 
Ò
 
 Analyses.
 
Analyses of T cell surface markers and
MHC class II were performed as previously described (20). Ex-
periments to assess cell surface binding of exogenous peptides us-
ing synthetic E
 
a
 
52-68 peptide and mAb YA
 
e
 
 were done as previ-
ously described (24).
 
T Cell Assays.
 
T cell hybrids specific for I-A
 
b
 
 bound to 
 
b
 
2m
48–58 (4.1) and IgM 377–392 (77.1) peptides have been previously
described (20). T cell hybrids specific for I-A
 
b
 
 bound to naturally
processed epitopes of actin (15.10), Clp36 (3.5), amino aspartate
aminotransferase (AAT) (15.15), and low density lipoprotein (LDL)
receptor (41.2) were generated after peptide immunization of
H-2M–deficient mice (Dongre, A., S. Kovats, P. deRoos, and
A.Y. Rudensky, manuscript submitted). Individual T cell hybrids
subcloned by limiting dilution were tested for MHC restriction
and peptide specificity using M
 
2
 
/
 
2
 
 APCs. T cell hybrids (2–10 
 
3
 
10
 
4
 
/well) were incubated with variable numbers of ex vivo spleno-
cytes (depleted of red blood cells) of the indicated genotype (10
 
2
 
–
10
 
6
 
/well) for 20 h. Peptide specificity of the T cell hybrids was
shown by addition of either cognate peptides or irrelevant peptides
(10 
 
m
 
g/ml) to cultures of M
 
2
 
/
 
2
 
 splenocytes (10
 
6
 
) and T cells.
 
Synthetic Peptides and Peptide Binding Studies.
 
Peptides were syn-
thesized on an automated peptide synthesizer (Synergy 432; Ap-
plied Biosystems, Foster City, CA) using F-moc chemistry. The
purity of peptides used was 
 
.
 
90%. For binding assays, affinity pu-
rified I-A
 
b
 
 (500 pM) was incubated with titrated amounts of in-
hibitor peptides (300 nM–700 
 
m
 
M) and biotinylated E
 
a
 
52–68
peptide (48 
 
m
 
M) for 16 h at 37
 
8
 
C in 0.1 M citrate-phosphate
buffer, pH 5.0, containing 1% octylglucoside. After neutralizing
pH, reaction mixtures were transferred into mAb Y3P-coated
plates and incubated for 4 h at 4
 
8
 
C. After washing, plates were in-
cubated for 2 h with Eu
 
3
 
1
 
-streptavidin (O.Y. Wallac, Turku,
Finland), then washed and read on a fluorometer (1234 DELFIA;
O.Y. Wallac) after adding fluorescence enhance solution (O.Y.
Wallac).
 
Results
 
The Absence of Ii Chain and H-2M Results in a Synergistic
Reduction in CD4
 
1
 
 T Cell Development.
 
Analyses of mice
lacking Ii have revealed a significant reduction in CD4
 
1
 
thymocytes, 20–30% of wild-type numbers, suggesting that
efficient CD4
 
1
 
 thymic selection requires high levels of sur-
face MHC class II molecules and/or the diverse array of
endogenous peptides that are displayed by thymic epithelial
cells in the presence of Ii. In contrast, in H-2M–deficient
mice, which display wild-type levels of class II molecules
predominantly occupied by a single peptide, CLIP, the
number of CD4
 
1
 
 thymocytes is significantly higher than in
Ii
 
2
 
/
 
2
 
 mice, 
 
z
 
30–50% of the number in wild-type mice.
To assess CD4
 
1
 
 T cell development in Ii
 
2/2
 
M
 
2/2
 
 mice,
thymocytes and splenic T cells were assessed by flow cy-
tometry for expression of CD4, CD8, and 
 
a
 
/
 
b
 
 TCR. The
total number of thymocytes did not vary significantly in the
mice of various genotypes. Three electronic gates were used
to analyze the presence of CD4
 
2
 
CD8
 
hi
 
TCR
 
hi
 
 (Fig. 1, box 
 
1
 
),
CD4
 
1
 
CD8
 
2
 
TCR
 
hi
 
 (Fig. 1, box 2), or CD41CD8loTCRlo
(Fig. 1, box 3) thymocyte populations isolated from mice
of five distinct genotypes (B6x129, Ii2/2, M2/2, Ii2/2M2/2,
and MHC-II2/2), shown as two parameter dot plots of
CD8 versus TCR-a/b in Fig. 1. The CD41CD8loTCRlo
cells (box 3) represent a minor population in a wild-type
thymus (Fig. 1 A), which is more prominent in an Ii2/2
thymus, concomitant with a marked decrease in CD41
TCRhi SP thymocytes (Fig. 1 B, box 2). In contrast, the
M2/2 thymus shows a 50% reduction in CD41TCRhi sin-
gle positive thymocytes (box 2) but no change in the in-
termediate (box 3) population (Fig. 1 D). Notably, the
Ii2/2M2/2 thymus shows a dramatic reduction (approxi-
mately sixfold relative to the Ii2/2 thymus) in the number
of CD41TCRhi cells (Fig. 1 C), similar to that observed in
mice lacking class II molecules (MHC-II2/2; Fig. 1 E). In
both Ii2/2M2/2 and MHC-II2/2 mice, virtually all of the
CD41 thymocytes display low levels of TCR and have in-
complete downregulation of CD8 (box 3). Thus, the par-
tial block in positive selection of CD4 SP thymocytes ob-
served in Ii2/2 thymi is exacerbated by the additional loss of
H-2M function in doubly mutant Ii2/2M2/2 thymi.
Analyses of peripheral T cells showed that the number of
splenic CD41 T cells in Ii2/2M2/2 mice were reduced rel-
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ative to the number in Ii2/2 or M2/2 mice (data not shown).
The level of TCR-a/b displayed on the surface of periph-
eral CD41 T cells in M2/2 mice was identical to that of
wild-type mice (Fig. 1 F). In contrast, Ii2/2 CD41 T cells
existed as two populations which differed in levels of TCR
expression, one of which overlapped with wild-type T
cells. Remarkably, CD41 T cells with normal TCR ex-
pression were not present in spleens of doubly mutant Ii2/2
M2/2 mice; the low level of TCR exhibited by all these
CD41 T cells coincided with that of the CD41TCRlo pop-
ulation in Ii2/2 mice (Fig. 1 F). This low level of TCR ex-
pression was also observed on all CD41 T cells present in
MHC-II2/2 mice. The level of TCR-a/b displayed on
splenic CD81 T cells from each of the mutant mice was
not different from that of wild-type T cells (Fig. 1 G). Thus,
Ii2/2M2/2 mice have a nearly complete block in normal
CD41 T cell development, akin to that observed in mice
lacking MHC class II molecules. These data led us to sug-
gest that a diverse repertoire of endogenous peptides is
achieved via an Ii-independent H-2M function and must
be displayed by class II molecules in the thymus in order to
achieve efficient CD41 T cell development. To test this
hypothesis, we next studied endogenous peptide:class II
complex formation in the double mutant mice.
Occupancy of Surface Class II Molecules with High-Affinity
Endogenous Peptides Was Diminished in Ii2/2M2/2 Cells.
The majority of I-Ab molecules that reach the cell surface
in the absence of Ii are associated with kinetically unstable
peptides or polypeptides that can be easily displaced by ex-
ogenous high-affinity peptides; in contrast, class II–bound
high-affinity peptides in wild-type cells cannot be displaced
(4). The surface expression of class II molecules on Ii2/2
and Ii2/2M2/2 splenocytes was reduced comparably about
fivefold relative to wild-type levels, as assessed by the I-Ab–
specific mAb Y3P (Fig. 2 A). To demonstrate endogenous
peptide occupancy of these surface class II molecules, wild-
type and mutant cells were loaded with 30 mM of the
Ea52–68 peptide and expression of the resulting Ea52–68–
I-Ab complexes was assessed with the complex-specific
mAb YAe (reference 24; Fig. 2, B and C). M2/2 cells did
not bind mAb YAe after incubation with Ea peptide. Rel-
ative to wild-type cells, Ii2/2 cells showed a threefold in-
crease in binding of mAb YAe. Significantly, the doubly
mutant Ii2/2M2/2 splenocytes showed a further modest in-
crease in mAb YAe binding. Since the fraction of class II
molecules containing high-affinity peptides in Ii2/2 spleno-
cytes is already small, resulting in very efficient loading of
surface class II molecules with exogenous Ea52–68, it may
be difficult to observe a further large effect of H-2M defi-
ciency on exogenous peptide loading. Nonetheless, these
data suggest that in the absence of both Ii and H-2M, even
fewer self-peptides are stably loaded onto class II molecules.
Presentation of Some Endogenous Self-peptides Requires H-2M
Even in the Absence of Ii-derived CLIP To investigate whether
H-2M acts to facilitate self-peptide binding in the absence
of CLIP, we assessed the ability of Ii2/2M2/2 splenocytes
to form particular endogenous self-peptide–I-Ab complexes.
Sequences of naturally processed self-peptides bound to
Figure 1. The absence of Ii chain and H-2M results in synergistic reduction of CD41 T cell development. Thymocytes from (A) wild-type B6x129
and mutant (B) Ii2/2, (C) Ii2/2M2/2, (D) M2/2, and (E) MHC-II2/2 mice were analyzed for expression of CD4, CD8, and TCR-a/b using flow cy-
tometry. Shown are two parameter dot plots of CD8 versus TCR-a/b, in which three electronic gates are indicated, delineating the following popula-
tions: CD42CD8hiTCRhi (box 1), CD41CD82TCRhi (box 2), and CD41CD8loTCRlo (box 3). Also shown are the percentages of cells that fall within
each box. Cells in boxes 2 and 3 are .97% CD41. Splenocytes from wild-type and mutant mice were analyzed for expression of CD4, CD8, and TCR-
a/b using flow cytometry. Shown are comparisons of TCR expression on (F) CD41 T cells and (G) CD81 T cells in the mice of the five genotypes, as
indicated. Data are representative of analyses of four mice of each genotype.
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I-Ab molecules in B cells or macrophages, corresponding to
portions of both membrane-bound and cytosolic proteins,
were recently identified in our laboratory using tandem
mass spectrometry (Dongre, A., S. Kovats, P. deRoos, and
A.Y. Rudensky, manuscript in preparation). The peptide
epitopes studied in this work include those derived from
membrane-bound proteins IgM (377–392), b2m (48–58),
LDLr (486–501), and cytosolic proteins actin (163–177),
Clp36 (138–153), and AAT (394–410). Synthetic peptides of
identical amino acid sequences to those eluted from class II
molecules were found to have a high affinity for purified
I-Ab in in vitro binding assays (Fig. 3), comparable to that
of the Ea52–68 peptide, a known high-affinity binder (24).
These peptides were used to generate antigen-specific T
cell hybrids upon immunization of H-2M2/2 mice (LDLr,
actin, AAT, Clp36) P. Dongre, S. Kovats, P. deRoos, and
A.Y. Rudensky, manuscript in preparation), or mice lack-
ing the specific self-protein, e.g., IgM2/2 or b2m2/2 (20).
These T cell hybrids were specific for the immunizing pep-
tide bound to I-Ab, as demonstrated by experiments in
which exogenous cognate peptide was added to M2/2 sple-
nocytes (Fig. 4, bar graphs). Irrelevant peptides added to
M2/2 APCs did not stimulate the T cell hybrids (data not
shown). The T cell hybrids also recognized endogenously
formed peptide–I-Ab complexes on wild-type splenocytes
(Fig. 4, line graphs).
A comparison of the ability of wild-type and mutant
APCs to form these endogenous peptide–I-Ab complexes
was obtained by incubation of variable numbers of ex vivo
isolated splenic APCs with a constant number of T cells in
the absence of exogenously added antigen (Fig. 4, A–F).
The comparison of Ii2/2 and Ii2/2M2/2 APCs allows di-
rect assessment of the role of H-2M, since the surface class
II expression is equivalent on splenocytes from these two
types of mice (Fig. 2). Each of the six epitopes was effi-
ciently presented by Ii2/2 splenocytes (Fig. 4). The re-
sponses of T cells specific for IgM, actin, AAT, and Clp36
epitopes were reduced by approximately fivefold, whereas
the responses of T cells specific for b2m and LDLr epitopes
were enhanced about twofold, relative to wild-type APCs.
These data indicate that these endogenous peptides can be
efficiently loaded in vivo onto class II molecules that traffic
through cellular compartments via an Ii-independent route.
In contrast, formation of the six distinct peptide–class II
complexes by doubly mutant Ii2/2M2/2 splenocytes was
much more variable, demonstrating differential require-
ments for H-2M function in the absence of CLIP. Presen-
tation of the IgM377–392 epitope was profoundly dimin-
ished in the absence of both Ii and H-2M, a striking result
since the IgM377–392–I-Ab complex is expressed very well
in Ii2/2 APCs (Fig. 4 A). Presentation of the b2m48–58
epitope was also significantly diminished in Ii2/2M2/2 APCs,
(reduced z10-fold relative to Ii2/2 APCs; Fig. 4 B). As
previously described (20), these two epitopes were pre-
sented at undetectable or very low levels by M2/2 spleno-
cytes (Fig. 4, A and B). Presentation of peptides derived
from the cytosolic antigens AAT and Clp36 by Ii2/2M2/2
splenocytes was diminished 5–10-fold relative to Ii2/2 APCs
(Fig. 4, E and F), while the already low level of presenta-
tion of the actin epitope by Ii2/2 deficient cells was not
profoundly affected by the absence of H-2M (Fig. 4 D). In-
terestingly, formation of LDLr486-501–I-Ab complexes was
essentially equivalent in Ii2/2 and Ii2/2 M2/2 cells (Fig. 4
C), and slightly enhanced relative to wild-type cells, sug-
gesting that this peptide preferentially binds to class II mol-
ecules via a mechanism independent of both Ii and H-2M.
As expected, since the T cells specific for LDLr, actin,
Figure 2. Occupancy of sur-
face class II molecules with high
affinity endogenous peptides is
diminished in Ii2/2M2/2 spleno-
cytes. (A) Cell surface class II ex-
pression on splenocytes from
wild-type and mutant mice was
assessed by the binding of bioti-
nylated mAb Y3P and streptavi-
din-PE, followed by flow cy-
tometry. Shown are profiles
from wild-type B6x129 (shaded
histogram), M2/2 (thick solid line),
Ii2/2 (thin dotted line), and Ii2/2
M2/2 (thin solid line) mice. For as-
sessment of peptide occupancy,
splenocytes were incubated in
the absence (0 mM) or presence
(30 mM) of synthetic Ea52–68
peptide (as indicated) for 3 h at
378C, before assessment of the
resulting Ea52–68–I-Ab complex
formation using biotinylated mAb
YAe and streptavidin-PE in flow
cytometric analyses. Shown is
binding of mAb YAe to (B) wild-
type B6x129 and M2/2 cells and
(C) Ii2/2 and Ii2/2 M2/2 cells.
Data are representative of four
independent experiments.
Figure 3. Endogenous peptides bind with high affinity to purified I-Ab
molecules in vitro. Purified I-Ab molecules were incubated with titrated
amounts of unlabeled test peptides and a biotinylated indicator peptide
Ea52–68. Subsequently, I-Ab molecules were captured on plates, and the
amount of biotinylated Ea peptide bound was quantified using Eu31-
streptavidin and fluorometry. Data were normalized to the maximal bind-
ing of biotinylated Ea52–68 (65,000–150,000 fluorescence units) in the
absence of inhibitor, and are reported as percentage maximal binding of
this indicator peptide. Shown are binding curves in the presence of unla-
beled Ea52–68 and a peptide that does not bind to I-Ab, L32 2–21. Back-
ground signal in the assay was 2,000–5,000 fluorescence units.
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AAT, and Clp36 peptides were generated in H-2M–defi-
cient mice, these peptides were not presented by M2/2
splenocytes (Fig. 4, C–F).
Discussion
In this report, we demonstrate that H-2M functions in
the in vivo loading of antigenic peptides onto class II mole-
cules in a capacity that is distinguishable from its previously
described role in CLIP removal. Using a panel of T cells
specific for high-affinity endogenous self-peptides bound to
the class II molecule I-Ab, we found that for the majority of
epitopes normally expressed in the absence of Ii, additional
loss of H-2M function significantly reduced the ability of
APCs to assemble these self-peptide–class II complexes. Thus,
even in the absence of Ii, class II molecules traffic through
the endocytic vesicles in which H-2M facilitates the bind-
ing of antigenic peptides. As a consequence of this deficient
loading of self-peptides, CD41 thymocyte development is
profoundly impaired in Ii2/2 M2/2 mice, resulting in a
peripheral CD41 T cell population with uniformly low lev-
els of TCR. Thus, we hypothesize that the normal diversity
of class II-bound endogenous peptides displayed on antigen
presenting cells, made possible by the disparate chaperone
functions of both Ii and H-2M, is required for develop-
ment of a complete repertoire of CD41 T cells.
Each of the endogenous epitopes we studied were pre-
sented well to T cells in the absence of Ii. With the excep-
tion of the response to the LDLr epitope, self-antigen–
specific T cell responses to Ii2/2M2/2 splenocytes were
reduced significantly relative to Ii2/2 APCs, suggesting that
even in the absence of Ii, some endogenous peptide–class II
complexes are formed in H-2M containing lysosomal com-
partments. There are two ways in which Ii-free class II
molecules may enter the endocytic pathway and potentially
benefit from the activities of H-2M. Cell surface class II
molecules can internalize into early endocytic vesicles via
signals in the cytoplasmic tails of class II a and b molecules,
a pathway that is also functional in Ii-expressing cells (25,
26). Alternatively, a lysosomal targeting signal present at
residues 80–82 of the class II b chain may facilitate entry of
newly synthesized class II molecules into the endocytic
pathway in the absence of Ii (27). In view of this, the self-
epitopes analyzed here may be generated efficiently and
Figure 4. Presentation of se-
lect endogenous self peptides re-
quires H-2M even in the ab-
sence of Ii-derived CLIP.
Activation of antigen-specific T
cell hybrids by ex vivo splenic
APCs isolated from wild-type
and mutant mice. Specificities of
the T cell hybrids are as follows:
(A) IgM 377–392, (B) b2m 48–
58, (C) LDLr 486–501, (D) actin
163–177, (E) AAT 394–410, and
(F) Clp36 138–153. Shown in
the left panels (line graphs, A–F)
are responses of T cell hybrids to
variable numbers of splenocytes
in the absence of exogenous
peptide; splenocytes derived
from wild-type B6x129 (squares),
Ii2/2 (open circles), M2/2 (trian-
gles), and Ii2/2M2/2 (closed circles)
mice are distinguished as indi-
cated. Shown in the right panels
(bar graphs, A–F) are responses of
T cell hybrids to M2/2 spleno-
cytes in the absence or presence
of exogenously supplied cognate
peptide (10 mg/ml). IL-2 pro-
duction by the T cell hybrids was
assessed by proliferation of HT-2
cells using an Alamar blue colori-
metric assay; results (average of
duplicate wells) are expressed as
arbitrary units of OD at 570 ver-
sus 600 nm. Data are representa-
tive of four independent experi-
ments.
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bind to class II in early or late endocytic compartments ac-
cessed by class II molecules internalized from the cell sur-
face or after diversion from the trans-Golgi network. Al-
though some of the high affinity self-peptides studied here
were presented in the absence of Ii and H-2M, the dra-
matic reduction of mature CD41 T cells in the Ii2/2M2/2
mice indicates that the function of H-2M is generally re-
quired in vivo to promote the binding of most self-peptides
to class II molecules.
H-2M may significantly increase the class II–bound rep-
ertoire of endogenous peptides in Ii2/2 APCs by virtue of
its ability to stabilize empty class II molecules or its capacity
to mediate replacement of a limited set of unstable polypep-
tides with a larger repertoire of relatively stable peptides.
Thus, it is perhaps unexpected that the absence of H-2M
did not decrease the steady-state level of I-Ab expression in
Ii2/2M2/2 APCs. However, since the majority of class II
molecules in Ii2/2 cells are unstably bound to low-affinity
polypeptides, the minor proportion of class II molecules
stably bound to high-affinity peptides in the presence of
H-2M may readily assemble with available polypeptides in
the absence of H-2M, thus maintaining an apparently simi-
lar level of surface class II expression. Alternatively, the ab-
sence of this minor population in Ii2/2M2/2 APCs would
not significantly affect total surface class II expression as mea-
sured by flow cytometry.
Biochemical experiments have shown that empty class II
a/b dimers are partially unfolded at pH 4.0–5.5 and tend
to form aggregates (28). HLA-DM is able to protect these
a/b dimers from denaturation through a stable interaction
(10, 15). In vivo, such chaperone activity would maintain
more class II molecules in a peptide-receptive state in en-
docytic vesicles until they contacted antigenic peptides, even-
tually increasing the number of stable peptide–class II com-
plexes at the cell surface. For the high affinity self-peptides
we studied, it is unlikely that the editing function of H-2M
was required to select for their stable binding. These pep-
tides are able to efficiently displace low stability or affinity
peptides or polypeptides bound to surface class II molecules
on Ii2/2 cells at neutral pH without the aid of H-2M (Fig.
2 and data not shown). Rather, H-2M may be primarily
enhancing their presentation by virtue of its ability to bind
to and prolong the half-life of empty class II a/b dimers at
acidic pH in vivo, as suggested by the in vitro studies.
The ability of a particular peptide to bind productively
to class II molecules in the absence of H-2M may depend
on its unique complement of amino acid side chains, or the
location and stability of the antigenic fragment within the
various endocytic vesicles. Thus, H-2M–independent pep-
tide binding would occur if the on-rate of the binding re-
action is very high, or if the half-life of an antigenic peptide
is greater than the half-lives of empty class II molecules, a
condition that might exist in the less proteolytic early endo-
cytic compartments that contain little or no H-2M (29–31).
In this regard, it is of interest to note that the LDL receptor
protein contains a targeting signal for early endosomes, which
may be the site where the H-2M– and Ii-independent epi-
tope of LDLr is generated (32).
Observations with singly mutant Ii2/2 or M2/2 mice
have indicated that efficient positive selection of CD41 T
cells requires high levels of surface class II molecules and/or
a diverse array of class II–bound endogenous peptides (3, 4,
17–19). Since the majority of surface class II molecules in
Ii2/2 APCs are apparently associated with unstably bound
peptides or larger polypeptides, the profound impairment
in CD41 T cell development in Ii2/2 mice suggests that
this majority of class II molecules does not mediate positive
selection. Rather, CD41 T cells in Ii2/2 mice are likely to
be selected on the small minority of stable endogenous
peptide–class II complexes that do reach the cell surface, al-
beit with a contracted repertoire of high-affinity endoge-
nous peptides. The absence of H-2M function in Ii-defi-
cient cells is likely to further decrease the diversity of the
class II–bound repertoire and/or the number of functional
endogenous peptides, which may be replaced with unstably
bound polypeptides. In both of these scenarios, steady state
surface class II expression would be similar to that of Ii2/2
cells. Although distinguishing between these two possibili-
ties is key to understanding the requirements for positive
selection in these mice, we currently lack the means to quan-
titate the proportion of class II molecules occupied with
high affinity peptides in Ii2/2 cells. Nevertheless, these re-
ductions in the number or diversity of functional peptides
apparently puts their expression below a threshold level re-
quired for CD41 positive selection in Ii2/2 M2/2 mice. In
view of our data, the impairment of CD41 thymic selec-
tion in M2/2 mice may be due to the dramatic reduction
in diversity of endogenous peptides bound to wild-type
levels of class II molecules, although this impairment may
be less marked than in Ii2/2 mice due to the high density
of the single CLIP peptide–class II complex.
In summary, our findings are consistent with the idea
that H-2M evolved as the primary chaperone assisting in
the loading of antigenic peptides onto MHC class II mole-
cules in the late endocytic compartment, presumably by pro-
moting the stability of empty class II a/b dimers. The facil-
itated dissociation of CLIP, and of other peptides that bind
to class II molecules with a high dissociation rate, may be
more specific manifestations of the general chaperone func-
tion of H-2M.
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